Fidelity Select Pharmaceuticals Portfolio (FPHAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
25.67
-0.22 (-0.85%)
Jun 13, 2025, 4:00 PM EDT
FPHAX Holdings List
As of Apr 30, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 26.16% |
2 | NVO | Novo Nordisk A/S | 12.86% |
3 | AZN | AstraZeneca PLC | 9.47% |
4 | EBR: UCB | UCB SA | 5.08% |
5 | GSK | GSK plc | 5.00% |
6 | RPRX | Royalty Pharma plc | 4.57% |
7 | GILD | Gilead Sciences, Inc. | 4.53% |
8 | MRK | Merck & Co., Inc. | 4.39% |
9 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.30% |
10 | LEGN | Legend Biotech Corporation | 2.27% |
11 | RNA | Avidity Biosciences, Inc. | 2.12% |
12 | ELAN | Elanco Animal Health Incorporated | 2.07% |
13 | EBR: TUB | Financière de Tubize SA | 1.40% |
14 | BNTX | BioNTech SE | 1.10% |
15 | ZTS | Zoetis Inc. | 0.99% |
16 | SNY | Sanofi | 0.98% |
17 | SWX: SDZ | Sandoz Group AG | 0.95% |
18 | LON: HIK | Hikma Pharmaceuticals PLC | 0.93% |
19 | XENE | Xenon Pharmaceuticals Inc. | 0.92% |
20 | PTCT | PTC Therapeutics, Inc. | 0.88% |
21 | JAZZ | Jazz Pharmaceuticals plc | 0.77% |
22 | RCUS | Arcus Biosciences, Inc. | 0.68% |
23 | OCUL | Ocular Therapeutix, Inc. | 0.68% |
24 | n/a | Metsera 180day Lu Line 7/30/25 | 0.57% |
25 | IRON | Disc Medicine, Inc. | 0.55% |
26 | MRNA | Moderna, Inc. | 0.55% |
27 | ASND | Ascendis Pharma A/S | 0.52% |
28 | AXSM | Axsome Therapeutics, Inc. | 0.52% |
29 | RARE | Ultragenyx Pharmaceutical Inc. | 0.46% |
30 | QURE | uniQure N.V. | 0.45% |
31 | BEAM | Beam Therapeutics Inc. | 0.41% |
32 | LUNG | Pulmonx Corporation | 0.39% |
33 | NTLA | Intellia Therapeutics, Inc. | 0.39% |
34 | MRUS | Merus N.V. | 0.35% |
35 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.35% |
36 | DYN | Dyne Therapeutics, Inc. | 0.33% |
37 | n/a | Cash | 0.31% |
38 | EBR: IBAB | Ion Beam Applications SA | 0.30% |
39 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.25% |
40 | HRMY | Harmony Biosciences Holdings, Inc. | 0.24% |
41 | n/a | Fidelity Cash Central Fund | 0.21% |
42 | AVBP | ArriVent BioPharma, Inc. | 0.19% |
43 | n/a | Paragon Biosc Emalex C Pc Pp | 0.17% |
44 | n/a | Agomab Therapeutic Ser D Pc Pp | 0.17% |
45 | n/a | Agomab Therapeutic Ser C Pc Pp | 0.17% |
46 | VKTX | Viking Therapeutics, Inc. | 0.16% |
47 | SMMT | Summit Therapeutics Inc. | 0.15% |
48 | VIR | Vir Biotechnology, Inc. | 0.15% |
49 | EWTX | Edgewise Therapeutics, Inc. | 0.12% |
50 | EBR: NYXH | Nyxoah SA | 0.11% |
51 | n/a | Castle Creek Bios Sr D-1 Pc Pp | 0.11% |
52 | n/a | Evozyne Cpik 6% 09/13/28 P/P | 0.09% |
53 | n/a | Evozyne Inc Ser B Pc Pp | 0.07% |
54 | MTSR | Metsera, Inc. | 0.03% |
55 | n/a | Paragon Bio Ser D-2 Pc Pp | 0.02% |
56 | n/a | Paragon Bio Inc Ser D-1 Pc Pp | 0.02% |
57 | n/a | Evozyne Inc Ser A Pc Pp | 0.01% |
58 | n/a | Castle Creek Bi Sr C Pc Prp Pp | 0.00% |
59 | n/a | Castle Creek Bios Sr D-2 Pc Pp | 0.00% |
60 | n/a | LEAP THERAPEUTICS INC WT | 0.00% |
61 | n/a | Medavail Holdings Inc Pipe | 0.00% |
62 | n/a | Eur Spot Cc | -0.00% |
As of Apr 30, 2025